NCT03353831 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03353831
Title	Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer
Recruitment	Completed
Gender	female
Phase	Phase III
Variant Requirements	No
Sponsors	AGO Research GmbH
Indications	ovarian cancer peritoneum cancer fallopian tube cancer
Therapies	Bevacizumab + Paclitaxel Bevacizumab + Pegylated liposomal doxorubicin Atezolizumab + Bevacizumab + Pegylated liposomal doxorubicin Atezolizumab + Bevacizumab + Paclitaxel
Age Groups:	adult \| senior
Covered Countries	SWE \| NOR \| LTU \| FRA \| FIN \| EST \| ESP \| DNK \| DEU \| CHE \| BEL \| AUT

NCT03353831
Clinical Trial Detail